The clinical effectiveness and costeffectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: A systematic review

  1. Fleeman, N.
  2. Saborido, C.M.
  3. Payne, K.
  4. Boland, A.
  5. Dickson, R.
  6. Dundar, Y.
  7. Santander, A.F.
  8. Howell, S.
  9. Newman, W.
  10. Oyee, J.
  11. Walley, T.
Zeitschrift:
Health Technology Assessment

ISSN: 1366-5278

Datum der Publikation: 2011

Ausgabe: 15

Nummer: 33

Seiten: 1-102

Art: Rezension

DOI: 10.3310/HTA15330 GOOGLE SCHOLAR lock_openOpen Access editor